Newron Pharmaceuticals Statistics

Total Valuation

SWX:NWRN has a market cap or net worth of CHF 364.89 million. The enterprise value is 373.64 million.

Market Cap	364.89M
Enterprise Value	373.64M

Important Dates

The next estimated earnings date is Thursday, December 18, 2025.

Earnings Date	Dec 18, 2025
Ex-Dividend Date	n/a

Share Statistics

SWX:NWRN has 19.96 million shares outstanding. The number of shares has increased by 16.86% in one year.

Current Share Class	19.96M
Shares Outstanding	19.96M
Shares Change (YoY)	+16.86%
Shares Change (QoQ)	-11.63%
Owned by Insiders (%)	4.81%
Owned by Institutions (%)	6.34%
Float	19.00M

Valuation Ratios

The trailing PE ratio is 16.44.

PE Ratio	16.44
Forward PE	n/a
PS Ratio	6.52
PB Ratio	246.95
P/TBV Ratio	247.11
P/FCF Ratio	15.93
P/OCF Ratio	15.90
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.31, with an EV/FCF ratio of 16.31.

EV / Earnings	15.80
EV / Sales	6.68
EV / EBITDA	11.31
EV / EBIT	11.36
EV / FCF	16.31

Financial Position

The company has a current ratio of 1.51, with a Debt / Equity ratio of 33.23.

Current Ratio	1.51
Quick Ratio	1.40
Debt / Equity	33.23
Debt / EBITDA	1.49
Debt / FCF	2.14
Interest Coverage	8.00

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	50.97%
Return on Invested Capital (ROIC)	60.97%
Return on Capital Employed (ROCE)	165.16%
Revenue Per Employee	2.54M
Profits Per Employee	1.08M
Employee Count	22
Asset Turnover	1.39
Inventory Turnover	n/a

Taxes

In the past 12 months, SWX:NWRN has paid 5.19 million in taxes.

Income Tax	5.19M
Effective Tax Rate	17.99%

Stock Price Statistics

The stock price has increased by +145.37% in the last 52 weeks. The beta is 0.68, so SWX:NWRN's price volatility has been lower than the market average.

Beta (5Y)	0.68
52-Week Price Change	+145.37%
50-Day Moving Average	15.00
200-Day Moving Average	9.65
Relative Strength Index (RSI)	64.15
Average Volume (20 Days)	109,719

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SWX:NWRN had revenue of CHF 55.93 million and earned 23.65 million in profits. Earnings per share was 1.11.

Revenue	55.93M
Gross Profit	55.93M
Operating Income	32.88M
Pretax Income	28.84M
Net Income	23.65M
EBITDA	32.89M
EBIT	32.88M
Earnings Per Share (EPS)	1.11

Full Income Statement

Balance Sheet

The company has 40.34 million in cash and 49.10 million in debt, giving a net cash position of -8.75 million or -0.44 per share.

Cash & Cash Equivalents	40.34M
Total Debt	49.10M
Net Cash	-8.75M
Net Cash Per Share	-0.44
Equity (Book Value)	1.48M
Book Value Per Share	0.07
Working Capital	19.04M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 22.94 million and capital expenditures -34,557, giving a free cash flow of 22.91 million.

Operating Cash Flow	22.94M
Capital Expenditures	-34,557
Free Cash Flow	22.91M
FCF Per Share	1.15

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of 58.78% and 42.30%.

Gross Margin	100.00%
Operating Margin	58.78%
Pretax Margin	51.57%
Profit Margin	42.30%
EBITDA Margin	58.81%
EBIT Margin	58.78%
FCF Margin	40.96%

Dividends & Yields

SWX:NWRN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.86%
Shareholder Yield	-16.86%
Earnings Yield	6.48%
FCF Yield	6.28%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SWX:NWRN has an Altman Z-Score of 4.83 and a Piotroski F-Score of 5.

Altman Z-Score	4.83
Piotroski F-Score	5